California Stem Cell Agency Ratifies $1 Million Clinical Trial for One Person, Puts Hold on Future One-Person Trial Proposals
CIRM's suspension is in place until rare disease award policy is formulated
BURLINGAME, Ca. -- A $1 million, “n of one” clinical trial for an extremely rare genetic disorder was approved last week by the California gene therapy/stem cell research agency, but its directors put a hold on the future acceptance of applications for such small trials.
The $1 million trial involves only one child, and the application raised policy con…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.